psoriasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Psoriasis patients aged 18-70 years with a disease course of = 6 months. (2) Have not received any biologics or small molecule targeted therapy within the past 3 months prior to screening; Not receiving traditional systemic therapy or phototherapy within one month prior to screening. (3) The patient voluntarily signs informed consent.
Exclusion criteria
Exclusion criteria: (1) Other types of psoriasis (drip type, erythrodermic type, pustular type, joint type), drug-induced psoriasis. (2) Other skin diseases that may interfere with the assessment of the condition. (3) Pregnant or lactating women. (4) Patients who are taking oral medication due to diabetes and dyslipidemia. (5) Major diseases that may interfere with research, including but not limited to severe infections, malignant tumors, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psoriasis area and severity index;Blood sugar and insulin levels;Blood lipid levels;Inflammatory indicators;cytokine; | — |
Countries
China
Contacts
The First Affiliated Hospital of Soochow University